Zobrazeno 1 - 10
of 230
pro vyhledávání: '"R G Wilcox"'
Autor:
J, Llevadot, R P, Giugliano, E M, Antman, R G, Wilcox, E P, Gurfinkel, T, Henry, C H, McCabe, A, Charlesworth, S, Thompson, J C, Nicolau, U, Tebbe, Z, Sadowski, E, Braunwald
Publikováno v:
European Heart Journal. 22:2104-2115
To compare management and clinical outcomes in hospitals stratified by the availability of on-site catheterization in InTIME-II, a multicentre trial comparing alteplase with lanoteplase for acute myocardial infarction.We studied 15,078 patients enrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b2da1ed58b27d5d8a13b6d9eb2191e
https://doi.org/10.1053/euhj.2001.2622
https://doi.org/10.1053/euhj.2001.2622
Autor:
F. Van de Werf, A. Luyten, R. Diaz, Marc Verstraete, J. R. Hampton, E. Sandoe, J. Simes, A Kristinsson, MariaGrazia Franzosi, T. van der Werf, G. Tognoni, L. Tavazzi, E A Paolasso, G. I. Barbash, J. Heikkila, K. Pehrsson, G von der Lippe, R. G. Wilcox, S Moulopoulos
Publikováno v:
The Lancet. 336:71-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::358a4999c73646110bfda4043b8b6f0a
https://doi.org/10.1016/0140-6736(90)91590-7
https://doi.org/10.1016/0140-6736(90)91590-7
Autor:
G A, Large, R G, Wilcox
Publikováno v:
Hospital medicine (London, England : 1998). 62(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d85fdccca84c33991092b22294226390
https://pubmed.ncbi.nlm.nih.gov/11530595
https://pubmed.ncbi.nlm.nih.gov/11530595
Autor:
R P, Giugliano, J, Llevadot, R G, Wilcox, E P, Gurfinkel, C H, McCabe, A, Charlesworth, S L, Thompson, E M, Antman, E, Braunwald
Publikováno v:
European heart journal. 22(18)
Aims We examined the geographic variations in InTIME-II, a randomized double-blind trial comparing alteplase with lanoteplase for myocardial infarction. Methods and Results We compared baseline characteristics, management, and outcomes in four region
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4d3020189282ce67349ed97148e322
https://pubmed.ncbi.nlm.nih.gov/11792142
https://pubmed.ncbi.nlm.nih.gov/11792142
Publikováno v:
Thrombosis and haemostasis. 85(3)
Platelet aggregation is the central process in the pathophysiology of acute coronary syndromes. ADP contributes to thrombosis by activating platelets, and AR-C69931MX is a specific antagonist of this process acting at the P2T receptor. At 5 hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::525a3b2cdffa164785944376beae28ec
https://pubmed.ncbi.nlm.nih.gov/11307804
https://pubmed.ncbi.nlm.nih.gov/11307804
Publikováno v:
The American journal of cardiology. 87(5)
We observed in a study of 7,651 patients with acute coronary syndromes that a white blood cell (WBC) count of10,000 was associated with increased 30-day and 10-month mortality (6.2% vs 3.2% to 3.6% for WBC count10,000; p0.000). With its simplicity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d2a906bf0d11a60802f649d91715e83a
https://pubmed.ncbi.nlm.nih.gov/11230853
https://pubmed.ncbi.nlm.nih.gov/11230853
Autor:
A B, Greenbaum, R A, Harrington, M P, Hudson, C M, MacAulay, R G, Wilcox, M L, Simoons, L G, Berdan, A, Guerci, D V, Cokkinos, M M, Kitt, A M, Lincoff, E J, Topol, R M, Califf, E M, Ohman
Publikováno v:
Journal of the American College of Cardiology. 37(2)
We aimed to evaluate the benefits of the glycoprotein (GP) IIb/IIIa antagonist, eptifibatide, after patients with acute coronary syndromes (ACS) were admitted to hospitals that approach revascularization for ACS through early transfer to tertiary ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1909727119790b73dd4890b0b99becc
https://pubmed.ncbi.nlm.nih.gov/11216968
https://pubmed.ncbi.nlm.nih.gov/11216968
Autor:
E, Boersma, K S, Pieper, E W, Steyerberg, R G, Wilcox, W C, Chang, K L, Lee, K M, Akkerhuis, R A, Harrington, J W, Deckers, P W, Armstrong, A M, Lincoff, R M, Califf, E J, Topol, M L, Simoons
Publikováno v:
Circulation. 101(22)
Appropriate treatment policies should include an accurate estimate of a patient's baseline risk. Risk modeling to date has been underutilized in patients with acute coronary syndromes without persistent ST-segment elevation.We analyzed the relation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::096e0b8bec9d801e9c4bf357929c603c
https://pubmed.ncbi.nlm.nih.gov/10840005
https://pubmed.ncbi.nlm.nih.gov/10840005
Autor:
D, Hasdai, D R, Holmes, D A, Criger, E J, Topol, R M, Califf, R G, Wilcox, E, Paolasso, M, Simoons, J, Deckers, R A, Harrington
Publikováno v:
American heart journal. 139(3)
Studies have shown that cigarette smokers constitute a substantial proportion of patients with acute coronary syndromes (ACS) and have platelet-rich coronary thrombi. We characterized the influence of smoking status on outcome of patients with ACS wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d495fab2caf89fcdcc13cd488d50f9c5
https://pubmed.ncbi.nlm.nih.gov/10689260
https://pubmed.ncbi.nlm.nih.gov/10689260
Autor:
N S, Kleiman, A M, Lincoff, G C, Flaker, K S, Pieper, R G, Wilcox, L G, Berdan, T J, Lorenz, D V, Cokkinos, M L, Simoons, E, Boersma, E J, Topol, R M, Califf, R A, Harrington
Publikováno v:
Circulation. 101(7)
Platelet glycoprotein (GP) IIb/IIIa antagonists prevent the composite end point of death or myocardial infarction (MI) in patients with acute coronary syndromes. There is uncertainty about whether this effect is confined to patients who have percutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5540e3b187db79841e52dd07bead4f93
https://pubmed.ncbi.nlm.nih.gov/10683348
https://pubmed.ncbi.nlm.nih.gov/10683348